Skip to search.
 TSX Down 0.08% TSX Ventures Up 0.73%

VIVUS Inc. (VVUS)

-NasdaqGS
1.02 Up 0.03(3.01%) Feb 5, 4:00PM EST
Prev Close:0.99
Open:1.00
Bid:1.00 x 4900
Ask:N/A
1y Target Est:8.27
Beta:0.299565
Earnings Date:Feb 22 - Feb 26 (Est.)
Day's Range:1.00 - 1.10
52wk Range:0.92 - 3.14
Volume:1,658,812
Avg Vol (3m):1,302,170
Market Cap:106.12M
P/E (ttm):N/A
EPS (ttm):-1.02
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
VVUSUp 3.01%106.12M
LLYUp 0.05%78.70B
PFEUp 0.10%179.22B
GSKDown 0.54%98.64B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1.01
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.95
Quarterly EPS Est (Dec-15) :-0.12
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):-1.34

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

VIVUS, Inc., a biopharmaceutical company, develops and commercializes therapies to address unmet needs in obesity, sleep apnea, diabetes, and sexual health in the United States and the European Union. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback